The 3rd Annual Companion Diagnostics (CDx) Summit Oncology & Beyond: Clinical Applications, Regulation, & Reimbursement 2017 covers topics such as:
- CDx, complimentary diagnostics (CoDx), and multiplexed CDx for precisely targeted population groups
- Emerging tools and discoveries to advance Companion Diagnostics (CDx) adoption
- Efficient regulation, reimbursement, & partnerships within the CDx landscape for oncology and beyond
- Optimised drug & diagnostics co-development road map
The 3rd Annual Companion Diagnostics (CDx) Summit Oncology & Beyond: Clinical Applications, Regulation, & Reimbursement 2017 brings together senior attendees from:
- Molecular Diagnostics
- Companion Diagnostics
- Biomarkers
- Personalised Healthcare
- Experimental Medicine
- Medical Sciences
- Clinical Development
- Translational Medicine
- Regulatory
- Clinical Trials
- Market Access
- Commercialisation
- Patient Advocates
- Payers
- Genomics
- Insurers
- Oncology
- Immunology
- Rare Diseases
- Non-oncology
- Research
- Drug Development
